您的位置: 首页 > 农业专利 > 详情页

11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt
专利权人:
CTI BioPharma Corp.
发明人:
Dymock, Brian,Lee, Cheng Hsia Angeline,William, Anthony Deodaunia
申请号:
AU2009325147
公开号:
AU2009325147B2
申请日:
2009.12.09
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The present invention relates to certain salts of a 11-(2-pyrrolidin-1-yl-ethoxy)-14,19- dioxa-5,7,26-triaza-tetracyclo[19.3.1.1 (2,6).1 (8, 12)]heptacosa- 1 (25),2(26),3,5,8,10,12(27),16,21,23-decaene (Compound I) which have been found to have improved properties. In particular the present invention relates to the citrate salt of this compound. The invention also relates to pharmaceutical compositions containing the citrate salt and methods of use of the citrate salt in the treatment of certain medical conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充